| Turkey | Thailand | South Korea | |
| Chemotherapy for breast cancer | from AUD $1,730 | from AUD $4,326 | from AUD $27,684 |
| CAR T-cell therapy | from AUD $216,278 | from AUD $360,463 | from AUD $555,113 |
| Leukemia chemotherapy | from AUD $11,535 | from AUD $21,628 | from AUD $31,721 |
| Therapeutic Apheresis | from AUD $1,947 | - | - |
Professor Zafer Gulbas is the founder and director of the Bone Marrow Transplantation Centre at Anadolu Medical Center.
Professor Bulent Karagoz is a senior medical oncologist at the JCI-accredited Anadolu Medical Center with deep expertise in tumour biology and immunotherapy.
Professor Sevindik is a hematology specialist at Istanbul Florence Nightingale Hospital who completed research training at the world-leading Mayo Clinic.
Professor Ceyhun Bozkurt is a leading specialist in childhood leukaemia and serves as the Clinical Director at Medical Park Bahcelievler Hospital. He has extensive experience in managing blood cancers and high-complexity stem cell therapy.
Leukaemia patients in Turkey access intensive care including chemotherapy, bone marrow transplants, and CAR T-cell therapy. JCI-accredited centres in Istanbul and Ankara provide multidisciplinary protocols. Leading specialists offer diagnostics like flow cytometry and MRD monitoring. Most clinics include VIP transfers and interpreters for Australian patients.
Bookimed Expert Insight: Turkey's leading haematologists often hold dual international credentials. Professor Zafer Gulbas and Professor Ceyhun Bozkurt trained at institutions like MD Anderson and Dana-Farber. This link to international oncology standards means patients receive the same protocols used in global hospitals at lower prices.
Patient Consensus: Patients highlight the comfort of modern facilities and the helpfulness of personal coordinators during long stays. Many note the high level of professionalism from doctors like Professor Zafer Gulbas in Istanbul.
Private Turkish hospitals are highly reliable for complex leukaemia care. Leading centres such as Anadolu Medical Center and Memorial Şişli Hospital hold Joint Commission International (JCI) accreditation. They offer therapies like CAR T-cell therapy and bone marrow transplants. Success rates reach 90% and higher.
Bookimed Expert Insight: Turkish haematology-oncology stands out because top professors often train at elite global institutions. These include MD Anderson or Fred Hutchinson. This creates an environment where Australian patients receive the same treatment protocols used in the USA or UK. For instance, packages at Medical Park Bahcelievler include multidisciplinary boards. These boards include cardiologists and radiologists to manage CAR T-cell therapy safely.
Patient Consensus: Patients in Turkey describe the care as a high level of service. They note that professors quickly inspire trust through professional behaviour and clear test results. Many note the support from on-site translators and companions. These staff handle everything from airport transfers to clinic navigation.
Leukaemia treatment protocols in Turkey typically require 2 to 3 years for complete cycles. Intensive induction phases last 2 to 6 weeks. Following this, consolidation therapy takes 3 to 6 months. Long-term maintenance therapy continues for several years to help maintain remission in acute cases.
Bookimed Expert Insight: Turkish haematology packages often include 28-day hospital stays as standard for intensive therapies like CAR T-cell. This is nearly double the typical surgical stay. Hospitals like Medical Park Bahcelievler Hospital list Australia as a served region. This means staff understand Medicare-related follow-up needs.
Patient Consensus: Patients in Turkey highlight the importance of clear phase-by-step timelines. They value having dedicated translators like Suleiman at Anadolu Medical Center to help with complex daily medical updates.
Australians face minimal language barriers in Turkey. Major leukaemia centres provide dedicated English-speaking coordinators and medical interpreters. Leading hospitals, including Anadolu Medical Center and Hisar Hospital Intercontinental, maintain Joint Commission International (JCI) accreditation. Specialists like Dr Zafer Gulbas often hold international credentials from institutions like MD Anderson.
Bookimed Expert Insight: Most coordinators speak English. Still, patients should choose university-affiliated clinics like Medipol Mega or Anadolu. These institutions have higher English proficiency among medical staff. For example, Dr Rafet Eren and Prof Dr Yesim Yildirim are fluent English speakers. This allows direct communication during complex CAR T-cell therapy or transplant discussions.
Patient Consensus: Patients in Turkey describe the support as high-level. They note that interpreters and companions accompany them at every stage. They appreciate that everything is organised for their comfort. This includes airport transfers and specialist consultations.
International patients choose Turkey for leukaemia treatment due to JCI-accredited facilities and specialised bone marrow units. Many centres now offer therapies like CAR T-cell therapy. Leading clinics like Anadolu Medical Center partner with Johns Hopkins Medicine International for multidisciplinary care. Highly trained specialists often offer immediate start dates without waiting lists.
Bookimed Expert Insight: Turkish haematology-oncology centres are uniquely structured for long-term intensity. Packages at Medical Park Bahcelievler Hospital include 28 nights of hospitalisation. This provides medical supervision throughout the critical initial recovery phase. Australian patients benefit from this, as standard international packages elsewhere often shift patients to hotels sooner.
Patient Consensus: Patients note Turkey offers much faster access to specialists than public health systems at home. They appreciate the coordinated logistics, including airport transfers and comfortable waiting areas. These features make the intensive diagnostic process feel easier.